Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

1,514

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Vancomycin Resistant Enterococci InfectionClostridium Difficile InfectionNosocomial InfectionMethicillin Resistant Staphylococcus Aureus Infection (MRSA)
Interventions
OTHER

Admission to a novel hospital ward

Hospital admission to a ward with novel infection control design features (e.g., abundance of sinks, predominance (80%) of private rooms, absence of shared bathrooms, absence of curtains)

Trial Locations (1)

T2N 2T9

Foothills Hospital, Calgary

All Listed Sponsors
collaborator

Calgary Health Region

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Alberta Heritage Foundation for Medical Research

OTHER

lead

University of Calgary

OTHER

NCT00563186 - Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial | Biotech Hunter | Biotech Hunter